Gorman Kevin Charles's Form 4 filing
Neurocrine Biosciences Inc (NBIX) · filed Sep 15, 2026
- Accession no.
- 0001201096-26-000018
- Filed
- Sep 15, 2026, 5:05 PM ET
- Trade date
- Sep 11, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gorman Kevin CharlesCIK 0001201096 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | Common Stock | AGrant or awardAcquired | +14,343 | $0.00 | $0 | 525,636 | Direct | |
| Sep 11, 2026 | Common Stock | FTax withholdingDisposed | −7,839 | $156.22 | −$1,224,608.58 | 517,797 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.